Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Accumulated Expenses: 2020-2022

Historic Accumulated Expenses for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $4.7 million.

  • Candel Therapeutics' Accumulated Expenses fell 22.86% to $3.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.4 million, marking a year-over-year decrease of 22.86%. This contributed to the annual value of $4.7 million for FY2022, which is 37.38% up from last year.
  • According to the latest figures from FY2022, Candel Therapeutics' Accumulated Expenses is $4.7 million, which was up 37.38% from $3.4 million recorded in FY2021.
  • Over the past 5 years, Candel Therapeutics' Accumulated Expenses peaked at $4.7 million during FY2022, and registered a low of $3.1 million during FY2020.
  • Its 3-year average for Accumulated Expenses is $3.8 million, with a median of $3.4 million in 2021.
  • Data for Candel Therapeutics' Accumulated Expenses shows a peak YoY surged of 37.38% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Candel Therapeutics' Accumulated Expenses stood at $3.1 million in 2020, then grew by 9.42% to $3.4 million in 2021, then skyrocketed by 37.38% to $4.7 million in 2022.